2023 AES: Special Lecture | Clinical Practice Guidelines: Why, What, How-Panel Discussion

Video Transcription

Video Summary

In a lively discussion, experts, including Dr. Hussain and Dr. Cooper, tackled the intricacies of referencing joint guidelines and the application of financial analyses in technical appraisals for guidance development. Dr. Hussain outlined the AES's ongoing and future guidelines on epilepsy, including collaborations with neurocritical care and maternal-fetal medicine societies. Dr. Parjan highlighted challenges in crafting clear, actionable guidelines, stressing the complexity of translating medical evidence into accessible recommendations. Participants voiced concerns about vague guideline terminology and insurer influence on clinical decisions. Additionally, forum members expressed interest in simplified guideline processes and transparency in proposal reviews. The session underscored the necessity of clear, evidence-based recommendations while recognizing the constraints imposed by legal and economic factors, prompting societies to balance practitioner autonomy with commercial pressures. The importance of stakeholder consultation in refining guidelines was emphasized as a means to preempt inconsistencies and misinterpretations.

Asset Subtitle

Presenters:
Renad Abu-Sawwa, PharmD
Aatif Husain, MD
Paul Cooper, DM, MA, FRCP, FAES
Karen Skjei, MD, FAES
Emily Johnson, MD, FAES

Keywords

guidelines

epilepsy

stakeholder consultation

financial analyses

medical evidence

transparency